Hoya Capital高股息收益ETF RIET 深 沪
交易中 04-01 11:08:25 美东时间
9.01
+0.020
+0.22%
华盛通- 最 高9.04
- 今 开9.01
- 成交量 1.30万股
- 最 低 8.965
- 昨 收 8.99
- 总市值 9640.70万
- 52周最高 9.6445
- 市盈率 静 --
- 换手率 0.12%
- 52周最低 7.934
- 委 比 9.09%
- 总股本 1070.00万
- 历史最高 14.2222
- 量 比 1.09
- 振 幅 0.83%
- 历史最低 6.2905
- 每 手 1
- 风险率 0.37%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Hydrofarm Q4 sales fall 33%; exploring strategic alternatives
Hydrofarm Q4 sales fall 33%; exploring strategic alternatives Overview U.S. hydroponics equipment maker's Q4 net sales fell 33% yr/yr amid industry oversupply Net loss widened sharply due to $232.2 mln impairment charge on intangible assets Company triggered default on term loan after deferring inte
03-27 20:12
EXCLUSIVE-US ramps up fuel exports to Cuba's private sector
EXCLUSIVE-US ramps up fuel exports to Cuba's private sector US shipped about 30,000 barrels so far this year Fuel flows only to private sector under US rules Trump administration has strict blockade on oil supplies to Cuban government By Dave Sherwood and Marianna Parraga HAVANA/HOUSTON, March 25 (
03-25 18:00
BRIEF-CBS News To Lay Off 6% Of Staff - Variety
BRIEF-CBS News To Lay Off 6% Of Staff - Variety March 20 (Reuters) - CBS NEWS TO LAY OFF 6% OF STAFF - VARIETY Source text: https://tinyurl.com/3f44hhxj Further company coverage: PSKY.O (( Reuters.Briefs@thomsonreuters.com ;))
03-20 21:40
BRIEF-Q/C Technologies Launches Optical Processing Unit (Opu) Initiative To Develop Proprietary Silicon Photonic Computing Architecture For Ai Inference
BRIEF-Q/C Technologies Launches Optical Processing Unit (Opu) Initiative To Develop Proprietary Silicon Photonic Computing Architecture For Ai Inference March 18 (Reuters) - Q/C Technologies Inc QCLS.O : Q/C TECHNOLOGIES LAUNCHES OPTICAL PROCESSING UNIT (OPU) INITIATIVE TO DEVELOP PROPRIETARY SILICO
03-18 21:22
BRIEF-Genvor Announces Strategic Expansion Into Health And Wellness Market, Leveraging Proprietary Ai-Accelerated Biocypher Platform To Develop Consumer Peptide Solutions
BRIEF-Genvor Announces Strategic Expansion Into Health And Wellness Market, Leveraging Proprietary Ai-Accelerated Biocypher Platform To Develop Consumer Peptide Solutions March 4 (Reuters) - Genvor Inc GNVR.PK : GENVOR ANNOUNCES STRATEGIC EXPANSION INTO HEALTH AND WELLNESS MARKET, LEVERAGING PROPRIE
03-04 21:01
BRIEF-Paramount's Revised Offer For Warner Bros. Discovery Will Likely Come In At $32/Share-Variety
BRIEF-Paramount's Revised Offer For Warner Bros. Discovery Will Likely Come In At $32/Share-Variety Feb 23 (Reuters) - PARAMOUNT’S REVISED OFFER FOR WARNER BROS. DISCOVERY WILL LIKELY COME IN AT $32/SHARE-VARIETY Source text: [ https://tinyurl.com/3mb6ztr8 ] (( Reuters.Briefs@thomsonreuters.com ;))
02-23 20:46
BRIEF-SerpApi Files Suit Against SearchApi For "Systematically Stealing" Proprietary Technology
BRIEF-SerpApi Files Suit Against SearchApi For "Systematically Stealing" Proprietary Technology Feb 17 (Reuters) - SerpApi: SERPAPI: FILES SUIT AGAINST SEARCHAPI FOR "SYSTEMATICALLY STEALING" PROPRIETARY TECHNOLOGY Source text: ID:nPn9qB9ypa (( Reuters.Briefs@thomsonreuters.com ;))
02-18 04:16
Angi misses Q4 revenue estimates on weakness in network revenue
Angi misses Q4 revenue estimates on weakness in network revenue Overview Home services platform's Q4 revenue fell 10%, missing analyst expectations Adjusted EBITDA for Q4 grew 25%, beating analyst estimates Company repurchased 19.9% of shares since IAC spin-off Outlook Angi expects to return to reve
02-11 05:17
BRIEF-STMicroelectronics Expands Engagement With Amazon Web Services On Compute Infrastructure
BRIEF-STMicroelectronics Expands Engagement With Amazon Web Services On Compute Infrastructure Feb 9 (Reuters) - STMicroelectronics NV STMPA.PA : STMICROELECTRONICS EXPANDS STRATEGIC ENGAGEMENT WITH AMAZON WEB SERVICES TO ENABLE NEW HIGH PERFORMANCE COMPUTE INFRASTRUCTURE FOR CLOUD AND AI DATA CENTE
02-09 14:17
BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAI
BRIEF-Clearmind Medicine Enters Development Agreement For Intranasal Formulation Of Proprietary Nonhallucinogenic Neuroplastogen MEAI Feb 6 (Reuters) - Clearmind Medicine Inc CMND.O : CLEARMIND MEDICINE ENTERS INTO DEVELOPMENT AGREEMENT TO ADVANCE INTRANASAL FORMULATION FOR ITS PROPRIETARY NON-HALLU
02-06 21:30
